AVGO vs. RYTM
AVGO (Broadcom Inc.) and RYTM (Rhythm Pharmaceuticals, Inc.) are both stocks. AVGO operates in Semiconductors (Technology), while RYTM operates in Biotechnology (Healthcare). Over the past 5 years, AVGO returned 54.08%/yr vs 38.52%/yr for RYTM. At a 0.23 correlation, their price movements are largely independent.
Performance
AVGO vs. RYTM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVGO achieves a 10.76% return, which is significantly higher than RYTM's -4.62% return.
AVGO
- 1D
- -2.69%
- 1M
- -0.04%
- 6M
- 19.77%
- YTD
- 10.76%
- 1Y
- 33.25%
- 3Y*
- 62.78%
- 5Y*
- 54.08%
- 10Y*
- 40.54%
- ALL TIME*
- 40.63%
RYTM
- 1D
- -0.55%
- 1M
- -5.07%
- 6M
- -0.75%
- YTD
- -4.62%
- 1Y
- 16.99%
- 3Y*
- 79.24%
- 5Y*
- 38.52%
- 10Y*
- —
- ALL TIME*
- 18.33%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AVGO Broadcom Inc. | $7.07B | $8.48B | $10.45B |
| $56.40M | $83.39M | $77.65M |
AVGO vs. RYTM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 10.76% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 6.86% |
RYTM Rhythm Pharmaceuticals, Inc. | -4.62% | 91.21% | 21.78% | 57.86% | 191.78% | -66.43% | 29.49% | -14.58% | -7.50% | 25.20% |
Correlation
The correlation between AVGO and RYTM is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 5, 2017 | 0.23 |
The correlation between AVGO and RYTM shifts across timeframes, from 0.09 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
AVGO:
$1.82T
RYTM:
$7.00B
AVGO:
$6.01
RYTM:
-$3.07
AVGO:
24.69
RYTM:
31.22
AVGO:
21.24
RYTM:
846.77
AVGO:
$75.47B
RYTM:
$217.17M
AVGO:
$50.53B
RYTM:
$194.16M
AVGO:
$42.03B
RYTM:
-$182.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVGO vs. RYTM — Risk / Return Rank
AVGO
RYTM
AVGO vs. RYTM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Broadcom Inc. (AVGO) and Rhythm Pharmaceuticals, Inc. (RYTM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVGO | RYTM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.33 | ||
| Sortino ratioReturn per unit of downside risk | +0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.10 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 1.17 | 0.48 | +0.69 |
| Martin ratioReturn relative to average drawdown | 2.37 | 1.08 | +1.29 |
Loading charts...
Drawdowns
AVGO vs. RYTM - Drawdown Comparison
The maximum AVGO drawdown since its inception was -48.30%, smaller than the maximum RYTM drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for AVGO and RYTM.
Loading charts...
Drawdown Indicators
| AVGO | RYTM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.30% | -92.10% | +43.80% |
Max Drawdown (1Y)Largest decline over 1 year | -28.67% | -35.54% | +6.87% |
Max Drawdown (3Y)Largest decline over 3 years | -41.15% | -35.54% | -5.61% |
Max Drawdown (5Y)Largest decline over 5 years | -41.15% | -84.18% | +43.03% |
Max Drawdown (10Y)Largest decline over 10 years | -48.30% | — | — |
Current DrawdownCurrent decline from peak | -20.57% | -13.20% | -7.37% |
Average DrawdownAverage peak-to-trough decline | -8.06% | -31.87% | +23.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.05% | 15.72% | -1.67% |
Volatility
AVGO vs. RYTM - Volatility Comparison
Broadcom Inc. (AVGO) has a higher volatility of 12.54% compared to Rhythm Pharmaceuticals, Inc. (RYTM) at 10.14%. This indicates that AVGO's price experiences larger fluctuations and is considered to be riskier than RYTM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVGO | RYTM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.54% | 10.14% | +2.40% |
Volatility (6M)Calculated over the trailing 6-month period | 34.10% | 33.95% | +0.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.24% | 45.24% | +2.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.88% | 76.35% | -32.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.69% | 71.27% | -31.58% |
Dividends
AVGO vs. RYTM - Dividend Comparison
AVGO's dividend yield for the trailing twelve months is around 0.67%, while RYTM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.67% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
RYTM Rhythm Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AVGO vs. RYTM - Financials Comparison
This section allows you to compare key financial metrics between Broadcom Inc. and Rhythm Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVGO vs. RYTM - Profitability Comparison
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
RYTM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported a gross profit of 52.96M and revenue of 60.11M. Therefore, the gross margin over that period was 88.1%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
RYTM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported an operating income of -52.36M and revenue of 60.11M, resulting in an operating margin of -87.1%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
RYTM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Rhythm Pharmaceuticals, Inc. reported a net income of -56.74M and revenue of 60.11M, resulting in a net margin of -94.4%.
Frequently Asked Questions
AVGO and RYTM have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (12.54%) compared to RYTM (10.14%). In terms of maximum drawdown, AVGO dropped -48.30% vs RYTM's -92.10%.
AVGO currently has the higher Sharpe Ratio (0.71 vs 0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVGO and RYTM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer